Leap Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LPTX and other ETFs, options, and stocks.

About LPTX

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

CEO

Doug E. Onsi

CEODoug E. Onsi

Employees

Employees54

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2011

Founded2011

Employees

Employees54

LPTX Key Statistics

Market cap

81.68M

Market cap81.68M

Price-Earnings ratio

-0.62

Price-Earnings ratio-0.62

Dividend yield

—

Dividend yield—

Average volume

209.46K

Average volume209.46K

High today

$3.28

High today$3.28

Low today

$3.01

Low today$3.01

Open price

$3.27

Open price$3.27

Volume

334.39K

Volume334.39K

52 Week high

$10.20

52 Week high$10.20

52 Week low

$1.24

52 Week low$1.24

Leap Therapeutics

Why Robinhood?

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA. Show more

LPTX Key Statistics

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.